Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced new data from an AstraZeneca ...

Some 77% of patients saw their tumours shrink, 8% saw them completely disappear, and 69% saw partial shrinkage of their ...

Dr. Singhi speaks with us about the importance of biomarker testing and what you need to know to get the best lung cancer treatment.

Bristol Myers Squibb (NYSE:BMY) and SystImmune reported data from an early-stage study testing their bispecific antibody-drug ...

In short, this research could lead to life-saving changes in how ILD is diagnosed and treated. By catching the disease early ...

Guardant Health is joining in on the American Lung Association’s (ALA’s) push to raise awareness about lung cancer screening and biomarker testing. The U.S. Preventive Services Task Force recommends ...

The global Early-Stage Lung Cancer Diagnostics Therapy Market is entering a transformative decade. With its valuation ...

In the histology-centric world of cancer medicine, further work is needed to increase genomic testing rates and educate ...

Cancer care is changing. More personalised therapies are available, for a variety of cancers, which target tumours that harbour specific genetic mutations. To prescribe these therapies, a genetic test ...

The Influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally.

Researchers have developed a 3D-printed lung tissue model that could help scientists better study and treat diseases.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...